Pharmafile Logo

long-term condition

- PMLiVE

AXON announces new roles for senior team members

Emma Kenny, Andy Grigg and Emma Lemon take on new responsibilities

- PMLiVE

Pfizer launches new antibiotic Zavicefta in UK and Germany

Biopharmaceutical company Pfizer releases MDR antibiotic

- PMLiVE

Keytruda claims first blood cancer OK from FDA

Merck & Co wins US approval for its haematological cancer treatment

- PMLiVE

Cello Health Consulting expands its UK team

Appoints John Tarplee, Eric de Regnaucourt, Jakub Kaczor and Namhee Lim

- PMLiVE

Mylan deal with Roche clears path to biosimilar Herceptin launch

Covers global markets with the exception of Japan, Brazil and Mexico

Dr Gopalan Narayanan joins VCLS

He takes up a 'disruptive biologics' role at the product development consultancy

Novartis day

FDA approval for Kisqali sets up showdown with Ibrance

Novartis breast cancer therapy drug has been predicted to reach blockbuster status

- PMLiVE

Amicus Therapeutics launches Fabry treatment Galafold in Italy

Follows publication of Ministry of Health's reimbursement guidelines

- PMLiVE

Merck confirms sale of biosimilar division

German pharma group is in 'advanced discussions' with potential buyers

GW Pharmaceuticals promotes Adam George to MD

And Scott Giacobello joins as chief financial officer

- PMLiVE

Trump nominates Gottlieb to head FDA

If confirmed he would take over from previous commissioner Robert Califf

- PMLiVE

Servier cleared to start US trials CAR-T therapy

FDA rules studies of its Pfizer-partnered drug can be resumed

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links